INTRODUCTION
UC is a relapsing and remitting chronic inflammatory condition confined to the mucosal layer of the colon. The pathogenesis is believed to be multifactorial including both genetic and environmental factors. [1] [2] [3] Residence in a Western industrialised country, antibiotic use, 4 5 GI infections [6] [7] [8] [9] and non-steroidal anti-inflammatory drugs 10 11 have been implicated as possible risk factors for the development of UC. Conversely, smoking [12] [13] [14] and appendectomy 5 15-22 have been negatively associated with the development of UC. Appendectomy is believed to alter the immune response profile in favour of suppressor T cells by decreasing the number of helper T cells and therefore decreasing interleukin 4 expression, a cytokine mediator in UC pathogenesis. [22] [23] [24] [25] Appendectomies performed in young T-cell receptor-α mutant mice, an animal model of UC, suppressed the development of colitis. 24 Multiple observational studies in humans have also demonstrated an inverse relationship between appendectomy and the development
Significance of this study
What is already known on this subject? ▸ Early appendectomy is inversely associated with the development of UC and may delay the onset of UC. ▸ Appendectomy may reduce the risk for colectomy in patients with UC and has been explored as a treatment for UC; however, this is based on observational studies, which shows conflicting evidence in the association between appendectomy and the need for total colectomy.
What are the new findings?
▸ Based on our findings and meta-analysis, appendectomy does not decrease the need for colectomy in patients with UC. ▸ If performed after UC diagnosis, appendectomy may increase the risk for colectomy.
How might it impact on clinical practice in the foreseeable future?
▸ Several previously published observational studies suggest that UC can be treated with appendectomy. Our data and subsequent meta-analysis show that appendectomy does not protect against colectomy. Therefore, our findings do not support the practice of appendectomy in the treatment of UC to prevent the need for total colectomy.
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of UC; however, studies evaluating the effect on UC severity, such as requiring a colectomy, have been conflicting. Some have shown a less severe disease course defined as either fewer relapses, a decrease in immunosuppressant requirements or a decrease in colectomy rates in patients with UC who underwent appendectomy. 17 18 26 27 Given its potentially protective role, appendectomy has been proposed as a treatment for UC and even as primary prevention for genetically susceptible individuals, 17 with several positive case reports. [28] [29] [30] [31] [32] [33] In contrast, other studies have demonstrated no difference in colectomy rates or need for immunosuppressants. 16 34 A systematic review from 2012 was not able to determine whether appendectomy was helpful, harmful or neutral on the disease course of UC since the included studies had heterogeneous outcomes including hospitalisation, escalation of medication and colectomy. 35 Since the appendix may play a role in modulating the development and disease course of UC, further investigation is needed to determine the effects appendectomy may have on UC disease course.
Our study had three aims. First, we evaluated whether appendectomy, performed at any time in relation to UC diagnosis, was negatively associated with severe UC, as defined by the need for colectomy. Second, we determined whether the timing of the appendectomy (ie, prior to or after UC diagnosis) was associated with colectomy rates. Finally, given the discrepancy of findings in prior literature, we performed an updated systematic review and meta-analysis to determine the effect of appendectomy, including the timing of appendectomy, on colectomy rates in patients with UC.
METHODS Population
We queried the phenotype database of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Inflammatory Bowel Disease Genetics Consortium. This large database includes >9000 participants with IBD and unaffected, non-IBD controls. Participants were recruited from the USA, Puerto Rico and Canada for genetic research studies. Phenotyping of IBD participants was performed according to a validated phenotype operating manual. 36 The validity of the phenotype classification using the definitions and procedures outlined in the manual has been previously described. 36 We included all patients with a confirmed diagnosis of UC from 1 January 2003 to 30 November 2013. Briefly, UC was defined as superficial inflammation and/or ulceration of the colon, which is continuous from the rectum extending proximally without any skip lesions and without inflammation of the small intestines. Patients with Crohn's disease or IBD undetermined type and participants with incomplete data on surgical or appendectomy history were excluded. Patients with UC with incomplete data who were excluded had no significant differences compared with those patients with UC with complete data who were included.
Patient data
Data recorded for each patient with UC included demographic background (sex, birth year, race and ethnicity), smoking status, first-degree relative with IBD, date of UC diagnosis, disease duration (time from diagnosis until most recently available medical records), disease extent, surgical history and the presence of any extraintestinal manifestations (EIMs), including any joint involvement, erythema nodosum, pyoderma, uveitis, episcleritis, undiagnosed ocular inflammation and primary sclerosing cholangitis (PSC). Smoking history was divided into never, former and current smoker at the time of UC diagnosis. Disease extent was categorised as having macroscopic evidence of inflammatory disease in the rectum ( proctitis), up to the splenic flexure (leftsided), or beyond the splenic flexure (extensive). If a patient underwent colectomy, the indication was recorded as either colorectal dysplasia or cancer, acute fulminant UC or chronic UC. Dates of appendectomy and colectomy were reported only as years, and therefore any appendectomy that occurred the same year as the colectomy was included in the no-appendectomy group as it was assumed that the appendix was removed during colectomy.
Statistical analysis
Categorical variables were compared using the χ 2 or Fisher test, where appropriate. Continuous variables were compared using the Student t test. Two variables had >3% missing data ( periappendiceal inflammation, 27%; surgery for dysplasia, 83%) and were therefore excluded from analysis. Missing data in the included variables were otherwise handled by model-wise deletion and excluded from the analysis. Univariable and multivariable logistic regression were used to estimate the relative odds of colectomy according to prior appendectomy status, while adjusting for potential confounders, including age at diagnosis, sex, race, smoking, family history of IBD, disease extent, presence of EIMs and disease duration. Use of Cox regression was not appropriate with the available data due to failing the proportional hazards test based on Schoenfeld residuals. Disease duration was measured as the time from disease onset to colectomy or most recent data collection, and binned as predefined durations of 0-5, 6-10, 11-20 and >20 years. Subgroup analyses included a similar evaluation of colectomy rates in two groups: patients with UC with pre-diagnosis and post-diagnosis appendectomy. Kaplan-Meier analysis was performed to evaluate colectomy-free survival over time. The log-rank test was used to compare colectomy-free survival between the two groups with or without prior appendectomy. A two-sided p value of <0.05 was considered statistically significant. All statistical analyses were performed using Stata V.12.1 (StataCorp, College Station, Texas).
This retrospective study with deidentified data is exempt from review by the Johns Hopkins Institutional Review Board (IRB).
Systematic review and meta-analysis
PubMed and EMBASE electronic databases were searched through 20 May 2015 for both UC and appendectomy using free text and MeSH or Emtree terms (see online supplementary table S1). Two independent reviewers screened the titles and abstracts for inclusion with adjudication by a third reviewer. An internal protocol was written to extract pertinent information.
Studies evaluating the effect of appendectomy on colectomy rates in patients with UC were included. Appendectomies performed both prior and after UC diagnosis were included, although they were separated for independent analyses. Studies that reported other effects of appendectomy such as medication escalation/de-escalation, hospitalisations, and clinical disease activity were excluded unless colectomy was reported.
The cases were defined as patients with UC that underwent appendectomy and the controls were defined as patients with UC that did not undergo appendectomy. The outcome of interest was colectomy rate. The timing of appendectomy-any time, prior to UC diagnosis and after UC diagnosis-was analysed separately as a secondary aim to determine whether timing of appendectomy had an effect on disease severity, defined as colectomy, in patients with UC.
The data extracted from each study included the total number of patients with UC included, the number of patients with UC that underwent appendectomy and the number that did not. The colectomy rates were recorded for each group of patients and 2×2 tables were created for each study. The OR was calculated for each individual study. Between-study heterogeneity was assessed by Q-statistic and quantified by I 2 . In the presence of statistical heterogeneity, evaluation of clinical characteristics of the studies, or leaving each study out, did not change the overall inference of the pooled estimate, thus a decision was made to present the overall OR. Publication bias was assessed by using the Harbord test.
RESULTS

Patient characteristics
There were 2980 patients with UC initially included in our study. Of the 2714 patients that had complete data on appendectomy and colectomy history including date of surgery, 111 (4%) had an appendectomy. Table 1 compares patient characteristics between patients with UC who did (n=111) and did not (n=2603) undergo appendectomy. The mean age of UC onset was delayed in patients who underwent appendectomy prior to UC diagnosis (41.8 years (SD=15.4) vs 30.8 (14.5) years, p<0.01). Sex, smoking status, family history of IBD, extent of disease, periappendiceal inflammation and presence of EIMs were not statistically different between the two groups. Patients with UC with appendectomy ( prior to or after UC diagnosis) had a higher rate of surgery for chronic UC compared with patients with UC without appendectomy (21.8% vs 14.0%, p=0.02).
Aim 1: does appendectomy, independent of the timing with UC diagnosis, associate with UC disease severity?
Appendectomy performed at any time was found to be associated with an increased risk of colectomy (OR 1.65, 95% CI 1.05 to 2.57, p=0.03). In the multivariable analysis adjusting for sex, race, smoking status, family history of IBD, presence of EIMs, disease duration and disease extent, appendectomy remained an independent risk factor for colectomy (OR 1.87, 95% CI 1.12 to 3.14, p=0.02) (table 2). This observation was confirmed over time in the appendectomy versus nonappendectomy patients with UC (figure 1).
A subanalysis was performed on patients with UC that underwent early appendectomy (defined as prior to age 20; see online supplementary table S2). There were 28 total patients with UC that underwent early appendectomy. Compared with patients with UC that did not undergo appendectomy, there was no difference in rate of colectomy in univariate (OR 1.05, 95% CI 0.39 to 2.83) or multivariate analysis (OR 0.75, 95% CI 0.20 to 2.90).
Aim 2: does timing of appendectomy with respect to UC diagnosis affect severity?
To evaluate how timing of appendectomy affects the disease course, we examined the 111 patients with UC who underwent appendectomy. Of these patients, 63 had an appendectomy prior to UC diagnosis and 48 after UC diagnosis. A subgroup analysis (adjusted for age, sex, race, smoking status, family history of IBD, disease extent, presence of EIMs and disease duration) was performed and found that appendectomy after UC diagnosis remained significantly associated with colectomy (OR 2.22, 95% CI 1.10 to 4.49, p=0.03), while an appendectomy performed before UC diagnosis was not significantly associated with colectomy (OR 1.52, 95% CI 0.73 to 3.19, p=0.27; figure 2). Our results suggest that the association with appendectomy regardless of the timing of UC diagnosis was mainly driven by appendectomy after UC diagnosis and not prior to diagnosis.
Other predictors of colectomy
In univariable analyses, colectomy was associated with male sex, earlier age at UC diagnosis, extensive disease and the presence of one or more EIMs ( PSC was not associated with a higher rate of overall colectomy in our UC cohort; however, PSC was associated with a higher rate of colectomy for dysplasia. Sensitivity analysis was performed to make certain this unique subset of patients were not skewing our data. All patients with UC with colectomy for dysplasia were first excluded and the outcome data was not changed (see online supplementary table S3). Secondly, all patients with PSC were excluded from analysis and again the data remained the same with appendectomy associated with colectomy changed (see online supplementary table S4).
Aim 3: updated systematic review and meta-analysis of appendectomy and appendectomy timing on UC disease severity
In order to examine whether our results were consistent with prior data and to perform a meta-analysis, we conducted a comprehensive review of the literature. The PubMed and EMBASE search resulted in 316 and 608 potential titles, respectively. After title and abstract review, a total of eight studies, including ours, met inclusion criteria including our current study. 16 17 26 27 34 37 38 One study was excluded since the primary outcome of interest was time to event. 17 Seven studies including our study 16 26 27 34 37 38 (7280 patients) examined the overall effect of appendectomy on the rate of colectomy in patients with UC (table 3; figure 3) . Overall, patients with UC who underwent appendectomy at any time in relation to UC diagnosis did not have a decreased rate of colectomy compared with patients with UC without appendectomy, (OR 1.17, 95% CI 0.92 to 1.50, I 2 =44.3%). Six studies, including ours, specifically evaluated the timing of appendectomy ( prior to or after UC diagnosis). Among those patients that underwent appendectomy before UC diagnosis (180 patients), there was no association between prior surgery and colectomy (OR 0.92, 95% CI 0.63 to 1.35, I 2 =50%). Analysis of patients that underwent appendectomy after UC diagnosis (4134 patients) did not show any protection from colectomy (OR 1.19, 95% CI 0.81 to 1.75, I 2 =10.9%) (figure 3). In both analyses (overall appendectomy and timing of appendectomy), none of the studies was highly influential and/or showed clinical heterogeneity. The Harbord test showed no evidence of publication bias ( p=0.49) (see online supplementary figure S1). Removing each study at a time did not change significantly the inference of the meta-analysis (see online supplementary figure S2).
DISCUSSION
The results of our large, multicentre study demonstrate that appendectomy, regardless of the timing with respect to UC diagnosis, does not decrease the severity of UC disease course, defined as the need for total colectomy, when compared with patients with UC who did not undergo appendectomy. In fact, our results suggest that performing appendectomy after UC diagnosis may be harmful as it showed a 2.2-fold increased risk of colectomy. Our updated systematic review and meta-analysis confirmed our findings and showed appendectomy had no effects on colectomy rates in patients with UC.
Appendectomy and UC disease severity
Previously published studies have suggested that appendectomy may predict a milder disease course for patients with UC. Naganuma et al 18 compared 325 patients with UC, 21 of whom underwent appendectomy prior to the diagnosis of UC and 304 who did not undergo appendectomy. Patients with a prior appendectomy had fewer relapses (57% vs 79%; p<0.05) and were less likely to have extensive colitis (38% vs 51%). Notably, this study had a small sample of patients with UC that underwent appendectomy, and the timing of the appendectomy was not specifically evaluated. 18 Radford-Smith et al 26 studied 307 patients with UC from the Brisbane IBD Research Group, 21 of whom had an appendectomy, and found a lower rate of Figure 1 Appendectomy is associated with a higher rate of colectomy independent of disease extent. Log-rank p=0.05. Figure 2 Post-UC appendectomy is associated with a higher risk of colectomy. Adjusted for sex, race, smoking status, first-degree relative with IBD, age at diagnosis of IBD, disease extent, presence of extraintestinal manifestations and disease duration.
colectomy in patients with a prior appendectomy (0% vs 21%, p=0.02) as well as a decreased need for immunosuppression (5% vs 25%, p=0.04). However, disease extent and disease duration were not controlled for, which are known predictors of colectomy in UC. 26 A study by Florin et al, also using the Brisbane database over the same period of time, demonstrated a decreased need for colectomy or immunosuppression for severe UC in patients with prior appendectomy (6% vs 25%, p=0.004). It should be noted that neither outcome on its own (colectomy or immunosuppression) was statistically significant and the number of patients with UC with appendectomy was quite small (19) . 27 Appendectomy has even been proposed as a treatment modality for UC.
28-30 33 39 There have been several case reports 33 39 including one by Okazaki et al 33 describing a case of mild UC proctitis 'cured' by appendectomy after 3 years of follow-up. The largest case series by Bolin et al in 2009 studied 30 patients with ulcerative proctitis who underwent an appendectomy for treatment of their disease. Almost all patients (90%) had some improvement in symptoms, with 40% of patients achieving complete resolution of symptoms. 30 Our findings call into question the use of appendectomy in the treatment of UC. These small case reports and case series may simply be publication bias and not indicative of the true outcomes of appendectomy in patients with UC.
Our study yielded a different conclusion: appendectomy was associated with a higher rate of colectomy in patients with UC in a multivariable analysis and was independent of all other factors studied including extent of disease and follow-up time. Notably, not all studies have detected a milder course in patients with UC who have undergone appendectomy. In a recent study, Lee et al 38 found no difference in colectomy rates in Korean patients with UC with and without appendectomy. A study from Mexico found a higher colectomy rate in patients with UC that underwent appendectomy although confounding factors were not controlled and timing of appendectomy was not reported. Figure 3 Meta-analysis of studies examining the effect of appendectomy on colectomy rates in patients with UC.
Hallas et al 34 studied 202 patients with UC who had undergone an appendectomy after UC diagnosis and found no difference in colectomy rates.
There are a number of possible explanations as to why appendectomy may or may not influence disease course. Previous studies suggest the reason appendectomy is inversely related to the development of UC is due to the presence of appendicitis and not simply the removal of the appendix. 20 40 41 Therefore, the removal of a healthy appendix may have no role in the clinical course of UC. Additionally, the appendix may have a role in the pathogenesis and development of UC, but not have a role in the subsequent clinical course once UC does develop. Patient factors may explain why our results contradict other studies since the majority of our patients had extensive disease and a mean disease duration over 10 years. However, a subanalysis of patients with UC with only proctitis found that appendectomy did not decrease colectomy rate (data available upon request). Lastly, perhaps the timing of appendectomy could be an influential factor in the clinical course of UC.
Timing of appendectomy
Early appendectomy has been shown to protect against the development of UC, thus supporting a role of the appendix in the pathogenesis of UC. 20 However, appendectomy after age 20 does not confer protection, 20 suggesting that cells involved in the development of UC may expand beyond the appendix to other lymphoid tissue after this age. 24 Since the age of appendectomy may be an important factor, a subanalysis of our data examining only those patients who underwent an appendectomy prior to age 20 was performed (see online supplementary table S2). Colectomy rates were still not decreased in patients with UC who underwent early appendectomy compared with patients with UC that did not undergo any appendectomy.
In our study, patients who underwent appendectomy prior to UC diagnosis had a significantly later onset of disease compared with patients with UC who did not undergo appendectomy; however, we did not observe a decreased risk of colectomy in this subgroup. Radford-Smith et al 26 and Selby et al 16 reported similar findings of delay in disease presentation in patients with prior appendectomy, further supporting the theory that the appendix plays a part in the pathogenesis of UC, but does not necessarily play a role in the clinical course once UC develops.
We noted that appendectomy performed after UC diagnosis was significantly associated with a 2.2-fold increased colectomy rate compared with patients with UC who did not have an appendectomy, whereas appendectomy performed prior to UC diagnosis did not affect the rate of colectomy.
The mechanism behind increased colectomy rates in patients with UC who underwent appendectomy after the UC diagnosis is unclear. Appendectomy in this already altered immunological environment may act as a trigger for more severe disease. There may also be pro-inflammatory changes in the microbiome that occur after appendectomy that have yet to be explained. Finally, it is possible that the development of appendicitis after UC diagnosis is a surrogate of already existing active disease. Counter to this argument, we found no difference in rates of pancolitis or periappendiceal inflammation between patients with UC who did or did not undergo appendectomy.
Other predictors of colectomy
Extensive disease [42] [43] [44] [45] and the presence of one or more EIMs 43 44 46 (both parameters of more advanced disease) were also associated with a higher risk for total colectomy. In our cohort of patients, 64% had extensive disease, which can be attributed to the tertiary and quaternary centres included in the NIDDK Inflammatory Bowel Disease Genetics Consortium. Other studies evaluating the effect of appendectomy on disease severity had lower rates of extensive disease. Therefore, disease extent was included in the multivariate analysis in examining the effect of appendectomy on colectomy rates. After controlling for disease extent and the presence of EIMs, appendectomy remained significantly associated an increased risk for total colectomy.
Systematic review and meta-analysis
Despite multiple studies investigating the role of appendectomy on UC disease severity, there was no consensus. Each study targeted different outcomes and had varied limitations. A prior systematic review was performed but did not narrow in on one outcome, and due to clinical heterogeneity, no meta-analysis could be conducted. 35 The authors concluded that there are inconsistent data but most studies suggest a beneficial effect of appendectomy on the course of UC. 35 Recently, Sahami et al 47 published a review that used some of the tools used in systematic reviews and meta-analyses; however, it is not, strictly speaking, 'a systematic review and meta-analysis' as it lacked core elements of meta-analyses (eg, assessment of statistical heterogeneity, publication bias Our updated systematic review with meta-analysis found, in contrast, no benefit of appendectomy on disease severity of UC measured by colectomy rates. In our meta-analysis, neither appendectomy prior to nor after UC diagnosis protected against severe disease. Based on an α error equal to 0.05, a power of 0.8 and fixed parameters based on each of the individual studies of the meta-analyses, we further conclude that, overall, the strength of the association between timing of appendectomy and the risk of total colectomy is absent or at most weak (see online supplementary table S6).
Our study has several strengths including the large sample size and the inclusion of multiple centres across several countries, which increases the external validity and generalisability of our findings. The patients were also well phenotyped following predefined protocols, which minimised risk of information bias. Furthermore, the collection of numerous variables into our primary analyses allowed the multivariate adjustment to control for potential confounders. As a result of our large sample size and comparatively large number of patients with UC with an appendectomy, we were able to separately analyse patients with appendectomy prior to UC diagnosis from those with appendectomy after UC diagnosis, whereas the majority of other studies did not. This may be an important distinction to make; given the associated immunological changes after the development of UC, appendectomy may no longer be protective. In order to overcome previous meta-analyses and address inconsistent results while increasing power to detect associations, we conducted a meta-analysis that showed that either overall appendectomy or timing of appendectomy did not influence the association with severity of UC as defined by rates of colectomy.
Our study has several limitations. The clinical scenario leading up to the appendectomy and the presence or absence of appendicitis on pathology was not known. Unfortunately, as a limitation of a retrospective database analysis we do not have access to information related to medication use. All sites that participated in the NIDDK Inflammatory Bowel Disease Genetics Consortium were tertiary and quaternary institutions and believed to have similar availability of medications such as biologics and immunomodulators. The study by Lee et al 38 included the need for steroids, biologics or immunomodulators and found no difference in between patients with UC with or without appendectomy. Selby et al 16 also evaluated the need for immunomodulator use and found no difference between patients with UC who did or did not have an appendectomy. Radford-Smith et al did find a decreased need for immunomodulators in patients with UC who had a prior appendectomy as well as a decreased need for colectomy. However, Radford-Smith's study did not control for disease duration and disease extent, which are known to be important independent predictors for colectomy. 26 Nevertheless, these data, along with pathological data on appendix, should be incorporated on prospective studies to better understand whether these characteristics mediate the association between appendectomy and colectomy.
Additionally, the database did not contain information on disease severity or hospitalisation, and therefore, colectomy is used as a surrogate for severity; nevertheless, we think that colectomy is a valid measure of disease severity as it has been shown in different studies. 16 17 26 27 34 37 38 Other factors were also analysed, including the coexistence of PSC, since PSC is an established risk factor for dysplasia and colectomy. When we excluded the 32 patients who underwent colectomy for dysplasia or 93 patients who had PSC in our cohort, the positive association between appendectomy and total colectomy did not change (see online supplementary tables S3 and S4). As with most large databases, there were incomplete data on some of the patients requiring exclusion of these patients, although this was quite minimal and the patients excluded had similar demographics and are not believed to be a skewed population.
In conclusion, in this large observational study with an updated meta-analysis, we found that appendectomy performed at any time in relation to UC diagnosis was not associated with a decrease in severity of disease. In fact, appendectomy after UC diagnosis may be associated with a higher risk of colectomy. Therefore, based on current observational data, appendectomy as a treatment for UC is not recommended. There is an ongoing prospective trial (ACCURE) investigating the effect of appendectomy on the clinical course of UC. 48 Until then, the current evidence does not support the therapeutic role of appendectomy in severe UC.
